{
  "pmcid": "12106023",
  "sha256": "3411efb3be8e5011045bcd9b9e396434b09ccb7e55309d2da58a105f696757b3",
  "timestamp_utc": "2025-11-09T22:15:28.376327+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.652668308702793,
    "reading_ease": 31.605789545703345,
    "word_count": 203
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Grey-to-White Matter Ratio in Predicting Neurological Outcomes in Heat Stroke"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included patients over 18 years with heat stroke who underwent cranial CT."
      },
      "Intervention": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the prognostic value of the grey-to-white matter ratio (GWR) in predicting neurological outcomes in heat stroke patients."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was neurological status at discharge, assessed by CPC scores."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomisation and blinding were not applicable due to the retrospective design."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Randomisation and blinding were not applicable due to the retrospective design."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "This multicentre retrospective study included 128 heat stroke patients from five hospitals in China between January 2020 and November 2023."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "All GWRs were significantly lower in the poor outcome group (CPC 3–5) than in the good outcome group (CPC 1–2)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: ChiCTR2400079671."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 12,
    "max_score": 25
  }
}